CPRD’s data provision services include access to CPRD Aurum containing primary care data from GP practices using EMIS GP software, in addition to Vision data from CPRD GOLD.
Data held by CPRD encompasses 42 million patient lives, including 13 million currently registered patients. The primary care data are near real time, longitudinal and representative of the UK population and can be linked to a range of health related datasets.
As a not-for-profit, cost recovery UK government research service, CPRD must recoup the cost of delivering research services from data access licence fees.
Multi-study annual licence (MSL) to CPRD primary care data:
CPRD offers an organisation-wide multi-study annual licence option for online access services to CPRD GOLD and CPRD Aurum. An MSL may be the most cost-effective option if an organisation anticipates conducting multiple patient-anonymised observational research studies using CPRD primary care data. Online data can be downloaded by the organisation for any number of individual ISAC-approved studies and for some internal studies that are exempt from ISAC review. The new MSL annual fee including cost for online access to the CPRD GOLD and CPRD Aurum and mandatory training for two designated users from the MSL holder organisation is:
Commercial Multi-study Licence Fee: up to £330,000
Non-Commercial Multi-study Licence Fee: £75,000
Prices exclude VAT.
Additional costs will be incurred for data linkages
Patient level primary care dataset for individual studies:
Patient level datasets for individual studies may also be accessed from CPRD. The current licence fees for accessing study-specific CPRD primary care datasets are shown below. Customers will be provided with the most suitable primary care data for their study which may be sourced from either or both of the CPRD GOLD database and the CPRD Aurum database.
Commercial Dataset Licence Fee: up to £60,000
Non-Commercial Dataset Licence Fee: £15,000
Prices exclude VAT.
Please contact firstname.lastname@example.org for further information or if you have any questions.
[Page last reviewed 4 October 2019]